Chronic Cough

A clinical trial for people who experience chronic cough, investigating the effects of different doses of oral medication.

Enquire Now

Sex
I consent to be contacted via text, email or phone(Required)
How would you like to be contacted?
Where did you hear about us?

We use this to understand which recruitment methods are working.
Privacy Notice we will only use your personal information for administration purposes and to provide information on upcoming medical trials relevant to you. Please read our full Privacy Notice and accept - Click Here
I have read Ormeau Clinical Trials Privacy Notice and agree(Required)

Trial Overview

A Phase 2b clinical trial is seeking to understand different doses of an investigational oral treatment and its potential effects on cough in patients with chronic cough.  During the trial, you will receive trial-related medical care from a dedicated team of healthcare providers.

The trial runs for about 13 weeks and involves 7 in-person visits, during which participants take an oral study drug under the supervision of a dedicated care team. It includes comprehensive medical testing, periodic use of a cough monitor, and electronic questionnaires.

Participation Criteria

  • Are an adult 18 years of age or older
  • Have a persistent cough for at least one year

What is Chronic Cough?

Chronic cough is a cough lasting more than 8 weeks in adults (or more than 4 weeks in children), as opposed to an acute cough linked to a short-term illness like a cold. It’s typically investigated with a combination of history-taking, examination, and sometimes tests such as chest X-ray, spirometry, or specialist referral if the cause isn’t clear. Treatment depends on the underlying cause, ranging from inhalers and reflux medication to stopping a triggering drug or addressing an underlying condition.

Find out more: 

Complete the enquiry form and a member of staff will be in contact to discuss further.

Call us on 028 9027 8380 to discuss with the team.